Related Experiment Videos

[Hepatitis B and C virus infections in children with congenital coagulation disorders]

S Alegría1, M Morales, J Vildósola

  • 1Sección de Gastroenterología, Hospital Roberto del Río, Santiago de Chile.

Revista Medica De Chile
|June 1, 1994
PubMed

Insights

Children with congenital coagulation disorders have high rates of hepatitis B and C virus infections, especially older children receiving more blood transfusions. This highlights a significant risk group for these blood-borne viral infections.

Area of Science:

  • Hepatology
  • Pediatrics
  • Hematology

Background:

  • Blood transfusions are essential for managing congenital coagulation disorders.
  • Hepatitis B and C viruses (HBV, HCV) are significant transfusion-transmitted infections.
  • Children with these disorders may have increased exposure to contaminated blood products.

Purpose of the Study:

  • To determine the prevalence of HBV and HCV infections in children with congenital coagulation disorders.
  • To identify risk factors associated with these viral infections in the studied population.

Main Methods:

  • Cross-sectional study involving 79 children with congenital coagulation disorders.
  • Serological testing for evidence of HBV and HCV infection.
  • Analysis of infection rates based on age and number of blood transfusions.

Main Results:

  • 29% of children showed evidence of HBV infection.
  • 52% of children showed evidence of HCV infection.
  • Higher infection rates were observed in older children and those who received more blood transfusions.

Conclusions:

  • Children with congenital coagulation disorders are a high-risk group for HBV and HCV infections.
  • Transfusion history and patient age are critical factors influencing infection risk.
  • Screening and prevention strategies are crucial for this vulnerable pediatric population.

Related Concept Videos